- Coordinator
- Universite D'aix Marseille, France
- Runs
- 1 January 2024 to 31 December 2026
- Status
- Running
- EU funding
- €4.9m
- Total cost
- —
- Partners
- 21 organisations in 11 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101131959
What the project is doing
In the project's own words, from its summary on CORDIS.
COVID-19 has highlighted the need for EU preparedness towards the growing number of virus outbreaks. Research infrastructures are strategic tools for providing resources and access to technologies for research, promoting innovation and supporting public health actions, but their impact is limited when they operate individually. The European Viral Outbreak Research Alliance (EVORA) project brings together three RIs (EVA, ERINHA-ESFRI and ELIXIR-ESFRI) with unique and complementary expertise in bio-banking, high containment facilities and data management solutions, respectively, under a single concerted interoperable framework with a common and long-term perspective.
EVORA aims to strengthen EU capacity for concerted preparedness and response to viral diseases, unify RI operations to achieve optimal RI responsiveness, sustainability and worldwide competitiveness and address specific regulatory, ethical, and security challenges related to emerging pathogens. EVORA will create synergies between the RIs through common governance and concerted decision-making mechanisms. The interoperability of EVORA services will be integrated, through unified operational procedures and quality standards, in order to support user needs and EU Health-Tech in either “inter-crisis” or “viral emergence response” conditions.
Finally, the project will address the complex regulatory aspects of preclinical research involving high-risk pathogens, to ensure the operability of the structure. By paving the way for a sustainable alliance of state-of-the-art RIs for preparedness and response to viral emergence, EVORA will strengthen the cohesiveness of the RI landscape in the field, contribute to the competitiveness of the European Research Area (ERA), and ultimately improve the EU's resilience to emerging communicable diseases.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universite D'aix Marseille | Marseille | France | Coordinator |
| Medizinische Universitat Graz | Graz | Austria | Third party |
| European Research Infrastructure on Highly Pathogenic Agents | Bruxelles / Brussel | Belgium | Participant |
| Katholieke Universiteit Leuven | Leuven | Belgium | Third party |
| Vib Vzw | Zwijnaarde - Gent | Belgium | Third party |
| Bernhard-Nocht-Institut Fuer Tropenmedizin | Hamburg | Germany | Participant |
| Charite - Universitaetsmedizin Berlin | Berlin | Germany | Participant |
| European Molecular Biology Laboratory | Heidelberg | Germany | Participant |
| Friedrich Loeffler Institut - Bundesforschungsinstitut Fuer Tiergesundheit | Greifswald-Insel Riems | Germany | Participant |
| Leibniz-Institut Dsmz-Deutsche Sammlung Von Mikroorganismen Und Zellkulturen GmbH | Braunschweig | Germany | Participant |
| Instituto De Salud Carlos Iii | Madrid | Spain | Third party |
| Institut National De La Sante Et De La Recherche Medicale | Paris | France | Third party |
| Institut Pasteur | Paris | France | Participant |
| Protisvalor Mediterranee SAS | Marseille | France | Third party |
| Nemzeti Nepegeszsegugyi Es Gyogyszereszeti Kozpont | Budapest | Hungary | Third party |
| Istituto Nazionale per Le Malattie Infettive Lazzaro Spallanzani-Istituto Di Ricovero E Cura a Carattere Scientifico | Roma | Italy | Third party |
| Erasmus Universitair Medisch Centrum Rotterdam | Rotterdam | Netherlands | Third party |
| Rijksinstituut Voor Volksgezondheid En Milieu (rivm) | Bilthoven | Netherlands | Participant |
| Instituto Nacional De Saude Dr. Ricardo Jorge | Lisboa | Portugal | Third party |
| Folkhalsomyndigheten | Solna | Sweden | Third party |
| Univerza V Ljubljani | Ljubljana | Slovenia | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI